Dicural
difloxacin
Table of contents
Overview
The marketing authorisation for Dicural has been withdrawn at the request of the marketing authorisation holder.
Authorisation details
| Product details | |
|---|---|
| Name |
Dicural
|
| Agency product number |
EMEA/V/C/000031
|
| Active substance |
difloxacin
|
| International non-proprietary name (INN) or common name |
difloxacin
|
| Species |
|
| Anatomical therapeutic chemical veterinary (ATCvet) codes |
QJ01MA94
|
| Publication details | |
|---|---|
| Marketing-authorisation holder |
Pfizer Limited
|
| Revision |
7
|
| Date of issue of marketing authorisation valid throughout the European Union |
16/01/1998
|
| Contact address |
Ramsgate Road
Sandwich Kent CT13 9NJ United Kingdom |
Product information
28/10/2015 Dicural - EMEA/V/C/000031 - IAIN/0021
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
-
Antibacterials for systemic use
-
Antiinfectives for systemic use
Therapeutic indication
Chickens:
for the treatment of chronic respiratory infections caused by sensitive strains of Escherichia coli and Mycoplasma gallisepticum.
Turkeys:
- For the treatment of chronic respiratory infections caused by sensitive strains of Escherichia coli and Mycoplasma gallisepticum.
- Also for the treatment of infections caused by Pasteurella multocida.
Dogs:
- For the treatment of acute uncomplicated urinary-tract infections caused by Escherichia coli or Staphylococcus spp. and superficial pyoderma caused by Staphylococcus intermedius.
Cattle:
- For the treatment of bovine respiratory disease (shipping fever, calf pneumonia) caused by single or mixed infections with Pasteurella haemolytica, Pasteurella multocida and / or Mycoplasma spp.